Advances in cryptococcal infections-associated immunopathology and potential therapeutic strategies [0.03%]
与 Cryptoccocal感染相关免疫病理学进展及潜在治疗策略
Nadezhda Sachivkina,Sarmistha Saha,Regina Gurina et al.
Nadezhda Sachivkina et al.
Globally, the Cryptococcus species, particularly Cryptococcus neoformans and Cryptococcus gattii, have a significant impact on human health. Concurrent with the evolving epidemiology of cryptococcosis, it has now become evident how host imm...
Comparative efficacy and safety of dual-combination vs. triple-combination antihypertensive therapies in hypertensive patients: an updated meta-analysis of randomized controlled trials [0.03%]
双药联合与三药联合降压治疗的疗效和安全性汇总分析
Zhuoling Gong,Lijun Huang,Xinru Long et al.
Zhuoling Gong et al.
Background: Combination therapy is often required for treating hypertension,but the comparative efficacy and safety of triple versus dual antihypertensive regimens remain to be clarified by the latest evidence-based medic...
Dobutamine versus milrinone for inferior ST-segment elevation myocardial infarction with right ventricular involvement: a retrospective cohort study [0.03%]
多巴酚丁胺与米力农治疗右心室受损的下壁ST段抬高型心肌梗死的回顾性队列研究
Si Wang,Qianfeng Xiao,Zhongming Li et al.
Si Wang et al.
Background: Inferior ST-segment elevation myocardial infarction (STEMI) complicated by right ventricular involvement (RVMI) leads to right-heart-dominant failure and a higher incidence of cardiogenic shock (CS). Evidence ...
Development of a core outcome set for traditional Chinese medicine for atrial fibrillation [0.03%]
房颤中医核心结局指标集合的研制
Chenyao Zhang,Zhongping Hao,Danni Li et al.
Chenyao Zhang et al.
Objectives: The inconsistent reporting of clinical trial results in patients with atrial fibrillation (AF) hinders the comparison of findings. Developing a core outcome set (COS) in studies evaluating traditional Chinese ...
Therapeutic advances in traditional Chinese and Tibetan medicine for high-altitude cerebral edema [0.03%]
高海拔脑水肿的中藏医药治疗进展
Yuhui Gao,Yupan Luo,Liqiong Chen et al.
Yuhui Gao et al.
Introduction: High-altitude cerebral edema (HACE) is an exacerbation of acute mountain sickness, but also a distinct disease characterized by vasogenic and cytotoxic brain edema. Exploring alternative therapies, such as t...
Fernanda Guilhaume-Correa,Rebekah Mannix
Fernanda Guilhaume-Correa
Peptidylarginine deiminase 4-mediated citrullination in human disease: molecular mechanisms and therapeutic targeting [0.03%]
肽精氨酸异构酶4介导的瓜氨酸化与人类疾病:分子机制和靶向治疗
Ping Zou,Xiao-Dan Su,Wei Tian et al.
Ping Zou et al.
Peptidylarginine deiminase 4 (PAD4) is a calcium-dependent enzyme that catalyzes protein citrullination, a post-translational modification that can alter protein charge, conformation, and function. Among the mammalian peptidylarginine deimi...
Hypertension associated with systemic therapy for hepatocellular carcinoma and management strategies [0.03%]
与肝细胞癌系统治疗相关的高血压及管理策略
Yuqing Li,Boxuan Wang,Dan Zhang et al.
Yuqing Li et al.
Antiangiogenic therapy and immune checkpoint inhibitors represent two cornerstone approaches in the current systemic treatment of patients with hepatocellular carcinoma (HCC). Since the advent of the immunotherapy era, the survival of patie...
Therapeutic effects of traditional Chinese medicine injections with heat-clearing and detoxifying properties on viral pneumonia: a systematic review and network meta-analysis [0.03%]
具有清热解毒功效的中药注射剂治疗病毒性肺炎临床疗效的系统评价和网络meta分析
Yuanchong Wang,Linlin Zhao,Lu Xiao et al.
Yuanchong Wang et al.
Background: The history of traditional Chinese medicine is extensive and well-documented. Various traditional Chinese medicine injections (TCMIs) with heat-clearing and detoxifying properties, developed from classical anc...
Comparative clinical outcomes and safety of finerenone, SGLT2 inhibitors, RAS inhibitors and ARNI in heart failure with preserved or mildly reduced ejection fraction: a systematic review and network meta-analysis [0.03%]
芬伦诺酮、钠-葡萄糖协同转运蛋白-2抑制剂、肾素-血管紧张素系统抑制剂和脑啡肽酶抑制剂在射血分数保留或轻度降低的心力衰竭患者中的临床疗效及安全性:系统评价与网络meta分析
Zimin Fu,Xin Chen,Haifeng Liu et al.
Zimin Fu et al.
Background: Although pharmacological therapies for heart failure have advanced, direct comparative evidence on the clinical outcomes and safety of finerenone versus other agents remains limited in HFpEF or HFmrEF. ...